Haifa, Israel

Hagit Neta

This inventor holds 2 USPTO granted patents. Top assignee: Protalix Ltd.. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hagit Neta. Retrieved from https://idiyas.com/inventor/hagit-neta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hagit Neta: Innovator in Modified DNase Technology

Introduction

Hagit Neta is a prominent inventor based in Haifa, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of modified DNase proteins. With a total of 2 patents to his name, Neta's work focuses on enhancing the efficacy of DNase I proteins for various medical applications.

Latest Patents

Neta's latest patents include innovations related to Modified DNase I proteins. These proteins are engineered by modifying one or more amino acids non-cellularly. The modified DNase I protein demonstrates improved DNA hydrolytic activity in the presence of actin, surpassing that of non-modified counterparts. The processes for preparing these modified proteins and their applications in reducing DNA content in sputum, as well as treating conditions associated with excess extracellular DNA, are also outlined in his patents.

Career Highlights

Hagit Neta is associated with Protalix Ltd., a company known for its advancements in biopharmaceuticals. His work at Protalix has positioned him as a key player in the biotechnology sector, contributing to innovative solutions for medical challenges.

Collaborations

Neta collaborates with notable colleagues, including Yulia Ugortsev and Yoseph Shaaltiel. These partnerships enhance the research and development efforts within his field.

Conclusion

Hagit Neta's contributions to the field of modified DNase technology reflect his commitment to advancing medical science. His innovative patents and collaborations underscore his role as a leading inventor in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…